Technical Analysis for COPHF - Creso Pharma Ltd

Grade Last Price % Change Price Change
B 0.0210 0.00% 0.0000
COPHF closed unchanged on Friday, March 31, 2023, on approximately normal volume. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a pullback should not be unexpected.

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Up Up

Date Alert Name Type % Chg
Calm After Storm Range Contraction 0.00%
Narrow Range Bar Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Overbought Stochastic Strength 0.00%
Calm After Storm Range Contraction 0.00%
Narrow Range Bar Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Overbought Stochastic Strength 0.00%
20 DMA Support Bullish 0.00%
50 DMA Support Bullish 0.00%

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
2x Volume Pace about 24 hours ago
1.5x Volume Pace about 24 hours ago

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.


Creso Pharma Ltd Description

Creso Pharma Limited develops, registers, and commercializes pharmaceutical-grade cannabis and hemp-based nutraceutical products and treatments for human and animal health in Europe, the Middle East, and the Asia Pacific. The company is involved in hemp growing operations, outsourced CBD extraction, and cannabidiol (CBD) product sales activities, as well as the development and commercialization of its therapeutic products. Its products include anibidiol, a natural complementary feed product for companion animals; and cannaQIX, a nutraceutical product containing organic hemp extract with CBD vitamins and zinc to reduce stress and support mental and nervous functions in humans, as well as topical and skin care products. The company also offers various nutraceutical products, such as cannaQIX®nite to aid sleep; cannaPEAL to introduce various markets to the benefits of hemp seed oil-based products; and cannaDOL to provide relief to athletes in the form of a topical application. In addition, it imports and sells its medicinal cannabis product, cannaQIX50 to patients in Brazil. Creso Pharma Limited has a strategic collaboration agreement with Hempmate AG Switzerland and Burleigh Heads Cannabis Pty Ltd. The company was incorporated in 2015 and is headquartered in Sydney, Australia.


Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Keywords: Health Cannabis Entheogens Euphoriants Hemp Medicinal Plants Drugs Health Sciences Herbs Medical Cannabis Herbalism Cannabidiol Skin Care Products Nutraceutical Products Nutraceutical Product Therapeutic Products Pharmaceutical Grade Cannabis

Is COPHF a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength


Indicator Value
52 Week High 0.117
52 Week Low 0.0012
Average Volume 14,644
200-Day Moving Average 0.0444
50-Day Moving Average 0.0166
20-Day Moving Average 0.0179
10-Day Moving Average 0.0192
Average True Range 0.0046
RSI 52.83
ADX 15.61
+DI 35.4489
-DI 57.4303
Chandelier Exit (Long, 3 ATRs) 0.0112
Chandelier Exit (Short, 3 ATRs) 0.0163
Upper Bollinger Bands 0.0327
Lower Bollinger Band 0.0031
Percent B (%b) 0.6
BandWidth 165.3631
MACD Line 0.0016
MACD Signal Line 0.0007
MACD Histogram 0.0009
Fundamentals Value
Market Cap 19.24 Million
Num Shares 916 Million
Price-to-Sales 10.97
Price-to-Book 22.49
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.0210
Resistance 3 (R3) 0.0210 0.0210 0.0210
Resistance 2 (R2) 0.0210 0.0210 0.0210 0.0210
Resistance 1 (R1) 0.0210 0.0210 0.0210 0.0210 0.0210
Pivot Point 0.0210 0.0210 0.0210 0.0210 0.0210
Support 1 (S1) 0.0210 0.0210 0.0210 0.0210 0.0210
Support 2 (S2) 0.0210 0.0210 0.0210 0.0210
Support 3 (S3) 0.0210 0.0210 0.0210
Support 4 (S4) 0.0210